ÂÜÀòÂÒÂ×

Dr. Carolin Mull is an experienced Clinical Trial Project Manager currently at SGS proderm since November 2023. Previously, Dr. Mull held roles as Clinical Affairs Manager at EUROIMMUN and Tiplu GmbH, and as Projektmanager in Clinical Operations at proderm GmbH. Dr. Mull has significant experience in research, having served as Forschungsleiterin at Asklepios Klinik Hamburg St. Georg and as a scientific employee in cell and molecular biology at Metavectum. Earlier academic contributions include a postdoctoral researcher in tumor biology at Universitätsklinikum Hamburg Eppendorf, along with a doctoral degree in tumor biology focusing on circulating tumor cells. Dr. Mull's educational background includes a Master of Science in Regulatory Affairs from Technische Hochschule Lübeck and a Diplom-Ingenieurin in Biotechnology from Hamburg University of Applied Sciences.